Introduction
Human T cell lymphotropic virus type I (HTLV-I), an exogenous, replication-competent retrovirus which has been aetiologically linked to adult T cell leukaemia/lymphoma (Takatsuki et al., 1977; Hinuma et al., 1981; Yoshida et al., 1982) , tropical spastic paraparesis/HTLV-I-associated myelopathy (Gessain et al., 1985; Rodgers-Johnson et al., 1985; Osame et al., 1986) , polymyositis (Morgan et al., 1989) , polyarthritis (Kitajima et al., 1989) and infective dermatitis (LaGrenade et al., 1990) , is endemic in the Caribbean basin, southwestern Japan and central and western Africa. HTLV-I infection, as verified by strict Western blot criteria, is also highly prevalent among the Hagahai, a small hunter-horticulturalist group living in the fringe highlands of Papua New Guinea, and among unrelated individuals from widely separated regions of the Solomon Islands . The recent isolation of genetically distinct, highly divergent sequence variants of HTLV-I from HTLV-I Western blotpositive inhabitants of Papua New Guinea and the Solomon Islands (Gessain et al., 1991 ; Yanagihara et al., 1991b, d, e; Sherman et aL, 1992) , viewed within the context of seroepidemiological studies (Kazura et al., 1987; Asher et at., 1988; Garruto et al., 1989 Garruto et al., , 1990 Armstrong et al., 1990; Imai et al., 1990; Sanders et al., 1990; Yanagihara et aL, 1990 Yanagihara et aL, , 1991a , establishes the endemicity of HTLV-I in Melanesia.
Serological surveys conducted among remote Melanesian populations also indicate high frequencies of individuals with indeterminate HTLV-I Western immunoblots (Asher et al., 1988; Garruto et al., 1989 Garruto et al., , 1990 Armstrong et al., 1990; Sanders et al., 1990; Yanagihara et al., 1990 Yanagihara et al., , 1991a . To determine whether these indeterminate HTLV-I Western blots reflect specific reactivity to the recently isolated sequence variants of HTLV-I, we studied seroindeterminate Melanesians from Papua New Guinea and the Solomon Islands for evidence of HTLV-I infection by Western blot analysis, gene amplification and virus isolation. Our data indicate that the high frequency of indeterminate HTLV-I seroreactivity among Melanesians is not due to HTLV-I infection.
Methods
Study population. Twenty members of the Hagahai (11 males, nine females; age range 14 to 62 years), a recently contacted, hunterhorticulturalist group living along the northern banks of the Yuat River Gorge in the westernmost corner of the Schrader Range in Madang Province of Papua New Guinea (Jenkins et al., 1989) , and 27 Melanesians (17 males, 10 females; age range 16 to 73 years) from widely separated regions of the Solomon Islands were studied. In addition, seven Polynesians (three males, four females; age range 16 to 60 years) from Bellona, Rennell and Tikopia, three of the so-called Polynesian Outliers within the Solomon Islands, were studied.
Specimens. Between March and August 1990, heparinized blood specimens were collected from the study participants, after obtaining informed consent. An aliquot of plasma was removed from each specimen and peripheral blood mononuclear cells (PBMC) were separated within 36 h of collection using Ficoll-Hypaque (Whittaker Bioproducts) in laboratories in which HTLV-I and other human and animal retroviruses had not been handled. Specimens from New Guineans were processed at the Papua New Guinea Institute of Medical Research in Goroka; those from Solomon Islanders were processed at the National Institutes of Health in Frederick, Maryland, U.S.A. PBMC from each individual were used for DNA isolation and the remainder was either preserved in 10~ DMSO and stored in liquid nitrogen prior to transport to the National Institutes of Health, or cultured immediately for virus isolation attempts.
Virus isolation. PBMC were stimulated with phytohaemagglutinin (PHA) (2 ~tg per 106 cells) for 3 days and maintained at 37 °C in a humidified 5% CO2/95% air atmosphere with biweekly changes of RPMI 1640 medium (Whittaker Bioproducts) supplemented with 20% (v/v) heat-inactivated foetal bovine serum, 10~ interleukin 2 (64 units/ml) (Pharmacia-ENI), 2 mM-L-glutamine and 50 ~tg of gentamicin/ml. Isolation attempts were also conducted by cocultivating PBMC with an equal number of PHA-stimulated umbilical cord blood mononuclear cells obtained from healthy Caucasian neonates (Advanced Biotechnologies) who lacked evidence of HTLV-I infection as determined by polymerase chain reaction (PCR). Cultures were examined periodically, over a 10-to 15-week period, for HTLV-I antigens by the indirect immunofluorescent antibody technique, using sera from Colombian and Chilean patients with HTLV-I myeloneuropathy and sera from rabbits experimentally infected with HTLV-I (Yanagihara et al., 1991 d, e) .
Western blot analysis. A 1:100 dilution of each serum was tested for reactivity to HTLV-I proteins by Western blot analysis, using nitrocellulose strips containing electrophoretically resolved proteins of HTLV-I from the HUT102 cell line (Cambridge-Biotech), the MT-2 cell line, derived from a Japanese patient with adult T cell leukaemia and the SI-5 cell line, a T cell line infected with an HTLV-I variant (HTLV-IM~L s) isolated from a Melanesian Solomon Islander . Briefly, culture media from SI-5 and MT-2 ceils were concentrated 500-fold by centrifugation for 1 h at 100000g and viral proteins, separated by electrophoresis on SDSpolyacrylamide gels (Laemmli, 1970) , were transferred electrophoretically to nitrocellulose membranes (Schleicher & Schuell) in 25 mMTris-HCl pH 7.4, 192 mM-glycine and 20~ methanol at 100 V for 1 h at 4 °C. Membranes were blocked for 2 h at room temperature with 50 mM-Tris-HCl pH 7.4 and 0.85~ NaC1 containing 5~ non-fat dry milk, then reacted overnight at 4 °C with each serum sample. Serum from a Colombian patient with HTLV-I myeloneuropathy served as the positive control. Finally, membranes were incubated with alkaline phosphatase-labelled goat antibodies against human IgG F(ab')2. Colour was developed using nitroblue tetrazolium (330 ~tg/ml) and 5-bromo-4-chloro-3-indolylphosphate (166 Ixg/ml) (Sigma).
There was good concordance between the results using the commercial Western blot and those using HTLV-I from the MT-2 cell line. Only sera reacting with HTLV-I gag-encoded proteins p19 and p24 and the major envelope glycoprotein gp46 were considered positive. Sera reactive to only gag gene products (either pl9 or p24 alone, or p 19/p24 and/or the gag precursor p53) or those reacting to p 19 and the recombinant transmembrane protein 21 e but lacking reactivity to gp46 were considered indeterminate. Sera exhibiting no reactivity were deemed negative.
PCR. High Mr DNA was isolated from fresh, uncultured PBMC and from PBMC maintained in culture for 4 weeks, using a non-organic method (Oncor). DNA from T cell lines infected with Melanesian variants of HTLV-I (HTLV-IMEt. 1 and HTLV-IMEL s) (Gessain et al., 1991 ; Nerurkar & Yanagihara, 1992; Sherman et al., 1992) , a T cell line infected with cosmopolitan prototype HTLV-I (MT-2) and an uninfected T cell line (MOLT-3) (ATCC) served as controls. All specimens were handled in an externally vented hood and reagents were dispensed into sterile tubes using positive-displacement pipetting devices (Rainin). Oligonucleotide primer pairs were specific for gag (De & Srinivasan, 1989) , pol (Kwok et al., 1988) , env (Reddy et aL, 1989) and tax sequences of a Japanese prototype strain of HTLV-I (ATK), and for env sequences of HTLV-I variants from the Solomon Islands and Papua New Guinea (Nerurkar & Yanagihara, 1992) (Table 1 ). In addition, primers specific for HTLV-II pol sequences (SK58, SK59) (Kwok et al., 1988) were employed. Primers were used at a final concentration of 1 ~tM in a reaction mixture containing 2 rtg of DNA, 2.5 units of Thermus aquaticus DNA polymerase (Perkin-Elmer Cetus), 50mM-KC1, 10mM-Tris-HC1 pH 8.3, 1.5 mM-MgC12 and 0-2 mM each dNTP. Using a DNA thermal cycler (Perkin-Elmer Cetus) the mixture was initially denatured at 94 °C for 4 min, then cycled 45 times at 94 °C for 1 rain, 55 °C for 1 min and 72 °C for 1.5 min, with a final extension of 7 rain at 72 °C before storing at 4 °C. Enzymatically amplified DNA was size-fractionated by agarose gel electrophoresis, and after alkaline denaturation and neutralization DNA was transferred to nylon membranes (Nytran; Schleicher & Schuell). Membranes were hybridized with a 32p.labelled full-length HTLV-I probe (Oncor) in 6 × SSC containing 50~ formamide, 0.5% SDS, 10% dextran sulphate and 501xg/ml heatdenatured salmon sperm DNA for 18 h at 42 °C. Membranes were then washed successively with 2 x SSC/0.5~ SDS for 20 rain at ambient temperature, 0.1 x SSC/0-1~ SDS for 40 min at 55 °C, and 0-1 x SSC for 5 rain at room temperature, then exposed overnight at -80 °C to X-ray film (Kodak X-Omat AR) with intensifying screens.
Results

Virus isolation
Long-term T cell lines were established from PBMC obtained from three of 11 HTLV-I Western blot-positive Melanesians and from one of two seropositive Polynesians. These cell lines have been previously described (Yanagihara et al., 1991b, d, e) . All attempts to isolate HTLV-I from PBMC obtained from the 27 HTLV-I Western blot-indeterminate Melanesians (and from the single seroindeterminate Polynesian) were unsuccessful. 
Western blot analysis
Eleven (three N e w Guineans and eight Solomon Islanders) of the 47 Melanesians possessed I g G antibodies against H T L V -I gag proteins p19 and p24 and the major envelope glycoprotein gp46, as determined by Western blot analysis using a cosmopolitan prototype and a Melanesian variant of H T L V -I (Fig. 1) . Reactivity to only gag proteins was found in 27 (17 N e w Guineans and 10 Solomon Islanders) and the remaining nine (all Solomon Islanders) were seronegative. Despite the higher frequency of reactivity to variant-specific p24, the serological status of the 27 seroindeterminate Melanesians (and the single Polynesian) was not altered by using a Melanesian H T L V -I variant as the antigen (Table 2 and Fig. 2 ). Interestingly, sera from Papua N e w Guineans did not react as strongly as did sera from Solomon Islanders to gp46 prepared from the SI-5 cell line (infected with HTLV-IMELS), further verifying the specificity of the Melanesian variants. In addition, sera from both seropositive and seroindeterminate Solomon Islanders reacted more strongly than did sera from P a p u a N e w Guineans to a 28K protein in Western blots prepared from MT-2 cell cultures (Fig. 1) . Table 2 and Fig. 3 ). The presence of cosmopolitan positive Polynesians attested to the specificity of the variant-specific env primers (Fig. 3) , H T L V -I I sequences were not detected in D N A from the 27 seroindeterminate and the nine seronegative individuals, using the H T L V -I I pol-specific primers (SK58 and SK59) and a 32p-labelled full-length H T L V -I I (MOT) probe. Furthermore, co-infection with H T L V -I and H T L V -I I was not found among the 11 Western blotpositive Melanesians.
D i s c u s s i o n
Indeterminate H T L V -I Western blots are frequently found with sera from Melanesian (Asher et al., 1988; Garruto et al., 1989 Garruto et al., , 1990 Armstrong et al., 1990; Yanagihara et al., 1990 and African individuals (Ouattara et al., 1986; Constantine & Fox, 1989; Delaporte et al., 1989 Delaporte et al., , 1991 . Among the remote Hagahai of Papua New Guinea and Melanesians of the Solomon Islands, more than 50 ~o of individuals who are repeatedly reactive to H T L V -I antigens by screening tests, such as ELISA, possess antibodies to only gag-encoded proteins by Western blot analysis (Yanagihara et al., , 1991a . A similarly high frequency of indeterminate Western blots has been found among Polynesians of the Solomon Islands (Asher et al., 1988; Garruto et al., 1989 Garruto et al., , 1990 Yanagihara et al., 1990) . Such reactivity has been variously interpreted as representing early seroconversion to HTLV-I, incomplete reactions to genetically distinct variants of H T L V -I or other retroviruses and cross-reactions to host or non-host antigens, particularly to parasites such as Plasmodiumfalciparum. Observations of cross-reactions between P. falciparum antigens and H T L V -I proteins among individuals living in a malarious region in the Philippines (Hayes et al., 1991) have not been found by other investigators for other malariaaffected populations in Papua New Guinea (Kazura et al., 1987; Sanders et al., 1990; Lal et al., 1991) , Indonesia (Jennings et al., 1991; Lal et al., 1991) and Africa (Delaporte et al., 1988) . Thus, it seems increasingly Guinea  3  3  3  3  3  3  3  3  3  1  3  3  Indeterminate  Solomon Islands  10  8 * Based on their seroreactivity to prototype HTLV-I proteins by Western blot analysis, Melanesians were categorized into one of three seroreactivity groups. Sera from individuals in each group were then tested for IgG antibodies against a Melanesian variant of HTLV-I, and DNA isolated from their PBMC was examined for HTLV-I genomic sequences by PCR.
t I~D, Not determined.
unlikely that seroreactivity to malarial antigens accounts for the indeterminate HTLV-I Western blot patterns in tropical populations.
With the recent isolation of HTLV-I variants from inhabitants of Papua New Guinea and the Solomon Islands, we sought to determine whether the high frequency of indeterminate Western blots in Melanesian individuals could be clarified by using variant-specific proteins and oligonucleotide primers. Our data indicate absolute concordance between serodiagnosis of HTLV-I infection by Western blot analysis and the detection of HTLV-I genomic sequences by PCR, using oligonucleotide primers specific for either prototype or variant gene sequences. Moreover, we were unable to isolate HTLV-I and to detect HTLV-I (and HTLV-II) genomic sequences in Melanesians (and Polynesians) with indeterminate Western blots. Similarly, as reported recently, HTLV-I genomic sequences have not been detected in the vast majority of seroindeterminate individuals from Gabon, Africa (Delaporte et al., 1991) .
The overall experience has been nearly identical for human immunodeficiency virus (HIV) infection among blood donors and homosexual men in the United States, as well as high-and low-risk groups in Africa. For example, in central Africa, where indeterminate HIV Western blots are exceedingly common, the cause of such seroreactivity has not been determined (Delaporte et al., 1988; Behets et al., 1991) . Among blood donors who have consistently indeterminate HIV-1 Western blots, attempts to demonstrate infection with HIV-1 or HIV-2 by virus isolation and gene amplification have been largely unsuccessful (Jackson et al., 1990; Dock et al., 1991) . However, in rare instances, HIV has been isolated from such individuals (Huet et al., 1989) and even from HIVseronegative persons (Imagawa et al., 1989) .
The serological status of seroindeterminate Melanesians, based on Western blot analysis using cosmopolitan prototype HTLV-I (e.g. HUT102, MT-2), was not altered by using a Melanesian HTLV-I variant as the antigen. However, it is unclear whether peptide-based immunoassays utilizing Melanesian variant-specific immunodominant epitopes will appreciably facilitate the serodiagnosis of HTLV-I infection in Melanesia and in other geographical regions where indeterminate HTLV-I Western blots are commonly found (Yanagihara et al., 1991c) .
Although infection with an HTLV-I variant was not excluded, the failure to verify screening test positivity by several confirmatory methods among inhabitants of Papua New Guinea led some investigators to conclude the existence of serological false positivity in Melanesia (Weber et al., 1989) . Our data do not exclude the possibility of infection with a novel retrovirus, but they indicate that infection with cosmopolitan prototype or Melanesian variant strains of HTLV-I is not the cause of the indeterminate Western blot reactivity seen in Melanesia. Studies, now in progress, are being aimed at identifying cross-reactive antigens in arthropod vectors and helminthic parasites, which are commonly found in geographical regions with high frequencies of indeterminate HTLV-I Western blots.
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